GSA Capital Partners »

Entrada Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $585k 37k 15.99
2024-06-30 $303k 21k 14.23

More positions owned by GSA Capital Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Global Ship Lease Com Cl A (GSL)
Staar Surgical Com Par $0.01 (STAA)
Progressive Corporation (PGR)
Accenture Plc Ireland Shs Class A (ACN)
Star Bulk Carriers Corp. Shs Par (SBLK)
Teck Resources CL B (TECK)
Vital Farms (VITL)
TJX Companies (TJX)
Fresh Del Monte Produce Ord (FDP)
Magnite Ord (MGNI)
Comcast Corp Cl A (CMCSA)

View all positions for GSA Capital Partners

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
T. Rowe Price Associates
BlackRock
StepStone
Geode Capital Management
Northern Trust
Jacobs Levy Equity Management
Charles Schwab Investment Management
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
Marshall Wace
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics